Defined by hepatic steatosis and at least one cardiometabolic risk factor such as type 2 diabetes mellitus (T2DM), obesity, or hypertension, MASLD affects over 30% of the global population
This is an open access article published under the terms of the Creative Commons Attribution 4.0 International License
For example, Dominos share prices have fallen following the recent announcements around GLP-1RAs (although they have since partially recovered)
These approaches are common among doctors who specialize in medical weight management, and as such, medical record data can be studied to inform future guidelines and standardization about maintenance-phase dosing in particular
The incretin effect in obese adolescents with and without type 2 diabetes: impaired or intact
Tesamorelin is meant to support, not replace, healthy habits